Increased prevalence of obesity and glucose intolerance in youth treated with second-generation antipsychotic medications.
about
First do no harm: promoting an evidence-based approach to atypical antipsychotic use in children and adolescents.Engaging families in research to determine health literacy needs related to the use of second-generation antipsychotics in children and adolescents.Barriers and facilitators to implementation of a metabolic monitoring protocol in hospital and community settings for second-generation antipsychotic-treated youth.Increased Risk of Obesity and Metabolic Dysregulation Following 12 Months of Second-Generation Antipsychotic Treatment in Children: A Prospective Cohort StudyHealth Information Preference among Youth and Caregivers related to Second-Generation Antipsychotic Treatment.The relationship between mental health diagnosis and treatment with second-generation antipsychotics over time: a national study of U.S. Medicaid-enrolled childrenPredictors of metabolic parameter monitoring in adolescents on antipsychotics in a primary care setting.Metabolic and cardiovascular adverse effects associated with antipsychotic drugs.Metabolic monitoring training program implementation in the community setting was associated with improved monitoring in second-generation antipsychotic-treated children.Eating disorders in adolescents with type 2 and type 1 diabetes.Weight gain and increase of body mass index among children and adolescents treated with antipsychotics: a critical review.Do antipsychotics increase diabetes risk in children and adolescents?Metabolic syndrome in an adolescent psychiatric unit.Electronic media use and addiction among youth in psychiatric clinic versus school populations.Enhancing metabolic monitoring for children and adolescents using second-generation antipsychotics.Waist circumference is a sensitive screening tool for assessment of metabolic syndrome risk in children treated with second-generation antipsychotics.Ten years of antipsychotic prescribing to children: a Canadian population-based study.Case of insulinoma manifesting as hyperinsulinemia after discontinuing quetiapine in an elderly patient with delirium.Fifty years of preventing and treating childhood behaviour disorders: a systematic review to inform policy and practice.
P2860
Q33845881-2CA23442-CB88-4CB8-994E-E006E1263236Q34124590-FF8F36BE-8033-4B79-B801-D1AF25377BD0Q34900812-AE783617-B4FA-4350-A952-6AE0F8A6520FQ36371705-2D51EB07-9B1B-4FBF-9626-9B1A15BECF1EQ36375877-C98C0636-27A4-4CCF-AC38-4082FC550283Q36442729-544ECF2F-7CB3-4022-AB30-D492669DBCF3Q36756538-E2DCA896-2B09-4BF4-9340-CFD26A868202Q37947095-115ADFFD-5CFF-4188-A844-E667E01FBFF0Q38006525-DC7B4E2C-F34A-4B74-B442-09D3DDD987A8Q38069758-E400CB2C-1628-4C54-8534-29C9A9F44585Q38090490-C8D4EB39-D179-42A9-BD9B-429B3E7873C5Q38283956-82D4BAE2-FC56-4BD2-AA73-616D6EE983A4Q44871652-F49439E4-0DF5-48BC-A8DF-9E653DA5AAD9Q46127907-ABF9DBCC-B53A-4303-A53E-F64E36C23104Q50072523-039FCDDA-DBA0-48A2-89C8-C386AA601086Q51361673-43F24B30-5608-4B51-BDD4-376B41E7828FQ51363558-432FE324-622E-41E9-9610-C5A92A9AC933Q54122592-7A725BE7-5778-4DC5-B98A-E2CC2D3CDD07Q55194919-63F34257-DE8D-47FB-8879-27146AF964F9
P2860
Increased prevalence of obesity and glucose intolerance in youth treated with second-generation antipsychotic medications.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Increased prevalence of obesit ...... ion antipsychotic medications.
@en
Increased prevalence of obesit ...... ion antipsychotic medications.
@nl
type
label
Increased prevalence of obesit ...... ion antipsychotic medications.
@en
Increased prevalence of obesit ...... ion antipsychotic medications.
@nl
prefLabel
Increased prevalence of obesit ...... ion antipsychotic medications.
@en
Increased prevalence of obesit ...... ion antipsychotic medications.
@nl
P2093
P2860
P1476
Increased prevalence of obesit ...... ion antipsychotic medications.
@en
P2093
Constadina Panagiotopoulos
Jana Davidson
Rebecca Ronsley
P2860
P304
P356
10.1177/070674370905401104
P407
P577
2009-11-01T00:00:00Z